November 2011
Washington DC —At a hearing today before the House Committee on Oversight and Government Reform, Ranking Member Elijah E. Cummings questioned health and medical experts about "gray market" drug companies that buy and sell drugs in critically short supply at exorbitant prices.
Washington, DC – Today, Rep. Elijah E.
Washington, DC – Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, sent a letter to Chairman Darrell Issa requesting that the Committee invite Dr. Susie Baldwin and Ms. Andrea Powell to testify at Thursday's hearing entitled "HHS and the Catholic Church: Examining the Politicization of Grants."
Washington, DC (Nov. 22, 2011)—Ranking Member Elijah E. Cummings released the following statement today regarding the public release of highly redacted "engagement letters" between mortgage servicing companies and independent consultants they hired to review past foreclosure abuses:
Washington, DC ?Ranking Member Elijah E. Cummings released the following statement regarding today's announcement from the Environmental Protection Agency (EPA) and the National Highway Traffic Safety Administration (NHTSA) about new greenhouse gas emission and fuel economy standards for Model Years 2017 to 2025 vehicles: